Clinical Trial Update: Modulation of Remifentanil-induced Postinfusion Hyperalgesia [Phase 4]

View source ↗

Summary

This clinical trial update reports on a Phase 4 study investigating strategies to modulate remifentanil-induced postinfusion hyperalgesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperalgesia

Drugs mentioned

• Remifentanil (remifentanil)

Snippet

Sponsor: Ullevaal University Hospital | Conditions: Hyperalgesia, Secondary | Phase 4 | Status: COMPLETED